Search Results
Results found for "Neel Freedman"
- Structural perspectives on the mechanism of signal activation, ligand selectivity and allosteric...
Thus, we need to know much more about the structures of receptor-ligand complexes at high resolution.
- Chronic itch: emerging treatments following new research concepts
However, many new targets, such as Mas-related GPCRs and unexpected new pathways need to be also explored
- TRPM3 in the eye and in the nervous system - from new findings to novel mechanisms
However, a clear picture is needed to unravel TRPM3's full potential as experimental tool, diagnostic
- G-protein-coupled receptors as therapeutic targets for glioblastoma
of life during treatment coupled with brain tumour recurrence; thus, new treatments are desperately needed
- Using Live-cell High-Content Screening to Characterize CB2 Ligands: Insights From 16 Synthetic Cannabinoids
and non-specific interactions introduce noise at precisely the stage where medicinal chemistry teams need physiologically grounded triage of ligand candidates—exactly the type of early clarity medicinal chemistry teams need
- High-Content Screening for GPCR Programs: Overcoming Assay Limitations with Fluorescent Ligands
Why Traditional Radioligand Methods Fall Short for Modern Screening Needs Radioligand binding assays provided as a complete CB2 HCS service—allowing teams to integrate fluorescent ligand technologies without needing
- Pharmacophore-guided Virtual Screening to Identify New β 3 -adrenergic Receptor Agonists
Hence, new β3 -AR agonists are needed as starting points for drug development.
- In vitro assays for the functional characterization of (psychedelic) substances at the serotonin...
variety, leading to insufficiently described structure-activity relationships, hence illustrating the need
- AlphaFold’s Breakthrough in GPCR Research: Revolutionizing Discovery, Yet Awaiting Experimental Proof
AlphaFold2 uses an AI-driven approach that eliminates the need for structural templates, allowing it
- Effect Delta-9-tetrahydrocannabinol and cannabidiol on milk proteins and lipid levels in HC11 cells
However, the increasing rate of cannabis use among pregnant women has presented an urgent need to investigate
- GPCR Happy Hour Boston 2026 — April 29 | Dr. GPCR Community Event
and reduce the risk and cost of developing new drugs, exactly the kind of intelligence GPCR programs need
- All About Addgene: More Open and Reproducible Science with Materials Sharing
If you need a plasmid for your research or you want to share your materials, this is the place to go.
- The GPCR antibody signal that should have been there
It is a way of building a GPCR antibody catalog out loud, alongside the people who feel the cost of getting
- Asking Better Questions in Science: A Practical Guide for Emerging Researchers
That first sentence is often the only barrier between you and the insight you need.
- Target Residence Time: The Hidden Driver of In Vivo Efficacy
diffusion to PK–PD dissociation, Kenakin equips you with the kinetic models and biological context needed
- From Pipettes to Platforms: The Evolution of GPCR Research
The GPCR field needs thinkers who can direct platforms, not just operate them.
- How GPCR Spatial Signaling Sparked a Scientific Journey
For Early-Career Scientists: Your pivotal moment might not feel like fireworks.
- Opposite Effects of Src Family Kinases on YAP and ERK Activation in Pancreatic Cancer Cells...
therapeutic options are limited, novel targets and agents for therapeutic intervention are urgently needed
- Why GPCR Biologic Drugs Stabilize Active States Small Molecules Struggle to Reach
An allosteric modulator does not need to engage the orthosteric contact network at all.
- Applications of Fluorescent Probes in Confocal Imaging of GPCRs: From Live to Fixed Cells
, our GPCR fluorescent ligands are designed with a variety of photophysical properties to meet your needs
- Why “Displacement” Misleads You: Allosteric Binding Demystified
Thermodynamics > Intuition: Why the Hall Cube Matters To untangle complex binding behaviors, you need
- Differential binding of Δ9-tetrahydrocannabinol derivatives to type 1 cannabinoid receptors (CB1)
If you are interested in our ligands or technology, feel free to contact me anytime. References 1.
- GPCR Allosteric Modulation: Why Allostery is the Engine of Drug Discovery
efficacy, selectivity, and SAR interpretation  ✅ Insight into cryptic binding sites  and why some drugs need
- 🎄 Have Yourself a Merry Little GPCRmas! ❄ Dec 9 - 15, 2024
Your feedback  will guide us in tailoring resources , tools , and content to meet your needs better and
- A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
agents.[1–3] These insights highlight the potential in modulating the ECS to fulfill unmet medical needs potency in the CB1R. [9,10] 1.2 Novel fluorescent strategies for CBR binding affinity assays Thus, the need If you have any questions about CELT-335 or the assays themselves, feel free to contact me!
- Activation of GPR183 by 7 α,25-Dihydroxycholesterol Induces Behavioral Hypersensitivity through...
Further investigation of the signaling pathways downstream of GPR183 is needed to support the development
- How Schild Analysis Protects Your Conclusions in GPCR Research
GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need
- How Breakthroughs Happen: Eric Trinquet on Innovation, Serendipity & GPCRs
It began with an unmet need: how to track Gq-coupled GPCR activity without the mess of calcium flux or
- đź“° GPCR Weekly News, October 2 to 8, 2023
No registration is needed to submit your logo design. Subscribe now to Dr.
- Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic ...
events in non-alcoholic steatohepatitis (NASH), an advanced form of NAFLD, is currently an unmet medical need


















